The Sr. Director, Patient Marketing Dual Asset Strategy position at argenx involves leading the commercial strategy for Vyvgart and preparing for the launch of Empa within the CIDP indication. The role seeks a seasoned professional with extensive biopharma experience, particularly in specialty or rare diseases, to drive growth and market positioning for these innovative therapies
Job Summary
The role is accountable for maximizing the growth of Vyvgart Hytrulo in CIDP while strategically preparing for the launch of Empa in MMN and CIDP.
Success requires balancing revenue growth with long-term portfolio strategy to shape the market and expand total franchise value.
Candidates must have a proven track record of driving performance for an in-market brand and managing complex multi-asset launches.
Matching Summary
Match Score: 85
The Sr. Director, Patient Marketing Dual Asset Strategy position at argenx involves leading the commercial strategy for Vyvgart and preparing for the launch of Empa within the CIDP indication. The role seeks a seasoned professional with extensive biopharma experience, particularly in specialty or rare diseases, to drive growth and market positioning for these innovative therapies.
Salary
Base: $236,000.00 - $324,500.00 USD; Bonus/Equity: Eligible for short-term and long-term incentive programs; Benefits: Comprehensive package including retirement savings and health benefits
Skills & Requirements
Must-have
12-15+ years biopharma commercial experience
Dual-asset strategy and lifecycle planning
Launch excellence for new assets
Market shaping and category expansion
Data-driven decision making
Nice-to-have
Experience with multi-indication portfolios
MBA or advanced degree preferred
Specialty or rare disease market expertise
Executive influence and strategic trade-off leadership
Key Requirements
12-15+ years of biopharma commercial experience
Launch experience required
MBA or advanced degree preferred
Deep patient marketing expertise in specialty or rare disease